The Infectious Diseases Society of America (IDSA) has recently released guidelines on pharmacologic therapies for COVID-19 . The guidelines are based on the latest clinical reports and consist of 32 recommendations to treat COVID-19 in patients with mild-to-moderate infection, severe but not critical infection, critical infection, and pre-and post-exposure prophylaxis treatment. We are publishing a series of articles on IDSA’s guidelines and here is an infographic on IDSA’s guidelines for treating pediatric patients with acute COVID-19 infection and COVID-19-mediated multisystem inflammatory syndrome in children (MIS-C).
To download the infographic, please click here! More IDSA’s guidelines on COVID-19 treatment: COVID-19 Treatment Guidelines Recommendations on lopinavir/ritonavir therapy Recommendations on Inhaled Corticosteroids COVID-19 Treatment with Convalescent Plasma How can we…
